SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort
Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2
inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported …
inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported …
Sodium‐glucose cotransporter 2 inhibitor canagliflozin antagonizes salt‐sensitive hypertension through modifying transient receptor potential channels 3 mediated …
Y Zhao, L Li, Z Lu, Y Hu, H Zhang, F Sun… - Journal of the …, 2022 - Am Heart Assoc
Background Salt‐sensitive hypertension is highly prevalent and associated with cardiorenal
damage. Large clinical trials have demonstrated that SGLT2 (sodium‐glucose cotransporter …
damage. Large clinical trials have demonstrated that SGLT2 (sodium‐glucose cotransporter …
DİYABET VE COVID-19
S İlin, Ş Kuşkonmaz - Ankara Eğitim ve Araştırma Hastanesi Tıp …, 2022 - dergipark.org.tr
At the end of 2019, a disease-mostly affecting the respiratory system-caused by the new
coronavirus was identified and named as COVID-19. This disease has rapidly spread all …
coronavirus was identified and named as COVID-19. This disease has rapidly spread all …
DİYABET VE CORONAVİRUS HASTALIĞI 2019 (COVID 19).
S ÎLÎN, ŞM KUŞKONMAZ - Medical Journal of Ankara …, 2021 - search.ebscohost.com
At the end of 2019, a disease-mostly affecting the respiratory system-caused by the new
coronavirus was identified and named as COVID-19. This disease has rapidly spread all …
coronavirus was identified and named as COVID-19. This disease has rapidly spread all …
[PDF][PDF] DİYabET VE COROnaVİRUS haSTaLıĞı 2019 (COVıD 19) DıabETES anD COROnaVıRUS DıSEaSE 2019 (COVıD-19)
S İLİN, ŞM KUŞKONMAZ - academia.edu
At the end of 2019, a disease-mostly affecting the respiratory system-caused by the new
coronavirus was identified and named as COVID-19. This disease has rapidly spread all …
coronavirus was identified and named as COVID-19. This disease has rapidly spread all …
[PDF][PDF] euglycemic and hyperglycemic
Methods Study design. We performed a cross-sectional, multicentre, retrospective study on
T2D patients taking SGLT2i who developed either EuDKA or hDKAfrom January 2015 to …
T2D patients taking SGLT2i who developed either EuDKA or hDKAfrom January 2015 to …